Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults

Clinical trial NCT07363395 · RECRUITING

Trial details

NCT number: NCT07363395
Sponsor: Alcamena Stem Cell Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2026-01-06
Primary completion: 2026-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.